Natural Product ID:   | NPC33382 |
Common Name:   | Toyocamycin |
IUPAC Name:   | 4-amino-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidine-5-carbonitrile |
Synonyms:   | |
Molecular Formula:   | C12H13N5O4 |
Standard InCHIKey:   | XOKJUSAYZUAMGJ-WOUKDFQISA-N |
Standard InCHI:   | InChI=1S/C12H13N5O4/c13-1-5-2-17(11-7(5)10(14)15-4-16-11)12-9(20)8(19)6(3-18)21-12/h2,4,6,8-9,12,18-20H,3H2,(H2,14,15,16)/t6-,8-,9-,12-/m1/s1 |
Canonical SMILES:   | OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cc(c2c1ncnc2N)C#N |
First Find Year:   | |
Max Developmental Stage:   | |
Synthetic Gene Cluster:   | BGC0000879;BGC0000881 ; |
Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO32842 | jaspis spp. | Species | Ancorinidae | Eukaryota | East coast of Malaysia | 1994 |
PMID[18327911] |
|
NPO18708 | Streptomyces diastatochromogenes | Species | Streptomycetaceae | Bacteria |
PMID[23775805] |
|||
NPO32432 | Streptomyces e-212 | Species | Streptomycetaceae | Bacteria | StreptomeDB* | |||
NPO4890.5 | Streptomyces rimosus atcc 14673 | Subspecies | Streptomycetaceae | Bacteria | StreptomeDB* | |||
NPO665.2 | Streptomyces diastatochromogenes 1628-vhb-23 | Subspecies | Streptomycetaceae | Bacteria | StreptomeDB* | |||
NPO29259 | Streptomyces toyocaensis | Species | Streptomycetaceae | Bacteria | StreptomeDB* | |||
NPO4890 | Streptomyces rimosus | Species | Streptomycetaceae | Bacteria | StreptomeDB* | |||
NPO665.1 | Streptomyces diastatochromogenes 1628 | Subspecies | Streptomycetaceae | Bacteria | StreptomeDB* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT195 | Organism | Vesicular stomatitis virus | Vesicular stomatitis virus | MIC | = | 0.07 | ug/ml | 6699874 |
NPT335 | Organism | Human coxsackievirus B4 | Human coxsackievirus B4 | MIC | > | 0.01 | ug/ml | 6699874 |
NPT1106 | Organism | Human poliovirus 1 | Human poliovirus 1 | MIC | > | 0.01 | ug/ml | 6699874 |
NPT2602 | Organism | Mammalian orthoreovirus 1 | Mammalian orthoreovirus 1 | MIC | > | 0.01 | ug/ml | 6699874 |
NPT336 | Organism | Human parainfluenza virus 3 | Human parainfluenza virus 3 | MIC | > | 0.01 | ug/ml | 6699874 |
NPT338 | Organism | Sindbis virus | Sindbis virus | MIC | > | 0.01 | ug/ml | 6699874 |
NPT190 | Organism | Human herpesvirus 1 | Human herpesvirus 1 | MIC | > | 0.04 | ug/ml | 6699874 |
NPT1141 | Organism | Human herpesvirus 2 | Human herpesvirus 2 | MIC | = | 0.07 | ug/ml | 6699874 |
NPT334 | Organism | Vaccinia virus | Vaccinia virus | MIC | > | 0.01 | ug/ml | 6699874 |
NPT195 | Organism | Vesicular stomatitis virus | Vesicular stomatitis virus | MIC | > | 1 | ug/ml | 6699874 |
NPT137 | Cell Line | L1210 | Mus musculus | ID50 | = | 0.006 | ug/ml | 6699874 |
NPT190 | Organism | Human herpesvirus 1 | Human herpesvirus 1 | MIC50 | > | 0.04 | ug/ml | 3820218 |
NPT1141 | Organism | Human herpesvirus 2 | Human herpesvirus 2 | MIC50 | > | 0.04 | ug/ml | 3820218 |
NPT334 | Organism | Vaccinia virus | Vaccinia virus | MIC50 | > | 0.04 | ug/ml | 3820218 |
NPT195 | Organism | Vesicular stomatitis virus | Vesicular stomatitis virus | MIC50 | > | 0.04 | ug/ml | 3820218 |
NPT195 | Organism | Vesicular stomatitis virus | Vesicular stomatitis virus | MIC50 | = | 0.07 | ug/ml | 3820218 |
NPT335 | Organism | Human coxsackievirus B4 | Human coxsackievirus B4 | MIC50 | > | 0.4 | ug/ml | 3820218 |
NPT1106 | Organism | Human poliovirus 1 | Human poliovirus 1 | MIC50 | > | 0.4 | ug/ml | 3820218 |
NPT2602 | Organism | Mammalian orthoreovirus 1 | Mammalian orthoreovirus 1 | MIC50 | > | 0.04 | ug/ml | 3820218 |
NPT336 | Organism | Human parainfluenza virus 3 | Human parainfluenza virus 3 | MIC50 | > | 0.04 | ug/ml | 3820218 |
NPT338 | Organism | Sindbis virus | Sindbis virus | MIC50 | > | 0.04 | ug/ml | 3820218 |
NPT335 | Organism | Human coxsackievirus B4 | Human coxsackievirus B4 | MIC50 | > | 0.04 | ug/ml | 3820218 |
NPT137 | Cell Line | L1210 | Mus musculus | MIC50 | = | 0.006 | ug/ml | 3820218 |
NPT137 | Cell Line | L1210 | Mus musculus | MIC50 | = | 38 | ug/ml | 3820218 |
NPT137 | Cell Line | L1210 | Mus musculus | MIC50 | = | 0.071 | ug/ml | 3820218 |
NPT137 | Cell Line | L1210 | Mus musculus | MIC50 | = | 0.039 | ug/ml | 3820218 |
NPT2603 | Individual Protein | Adenosine kinase | Homo sapiens | IC50 | = | 310 | nM | 11958989 |
NPT2603 | Individual Protein | Adenosine kinase | Homo sapiens | IC50 | = | 3228494122 | nM | 11958989 |
NPT2 | Others | Unspecified | EC50 | = | 12 | nM | 11020285 | |
NPT319 | Cell Line | B16 | Mus musculus | EC50 | = | 5 | nM | 11020285 |
NPT2 | Others | Unspecified | EC50 | = | 4 | nM | 11020285 | |
NPT1750 | Organism | Human herpesvirus 5 | Human herpesvirus 5 | IC50 | = | 1700 | nM | 2175356 |
NPT1750 | Organism | Human herpesvirus 5 | Human herpesvirus 5 | IC90 | = | 14000 | nM | 2175356 |
NPT190 | Organism | Human herpesvirus 1 | Human herpesvirus 1 | IC50 | = | 29000 | nM | 2175356 |
NPT190 | Organism | Human herpesvirus 1 | Human herpesvirus 1 | IC90 | = | 3500 | nM | 2175356 |
NPT859 | Cell Line | HFF | Homo sapiens | IC50 | = | 8000 | nM | 2175356 |
NPT1750 | Organism | Human herpesvirus 5 | Human herpesvirus 5 | IC50 | = | 50 | nM | 8632411 |
NPT859 | Cell Line | HFF | Homo sapiens | IC50 | < | 10 | nM | 8632411 |
NPT91 | Cell Line | KB | Homo sapiens | IC50 | = | 30 | nM | 8632411 |
NPT137 | Cell Line | L1210 | Mus musculus | IC50 | = | 4 | nM | 2913300 |
NPT1750 | Organism | Human herpesvirus 5 | Human herpesvirus 5 | IC50 | = | 50 | nM | 2913300 |
NPT2603 | Individual Protein | Adenosine kinase | Homo sapiens | IC50 | = | 3235936569 | nM | 15149648 |
NPT1750 | Organism | Human herpesvirus 5 | Human herpesvirus 5 | IC50 | = | 100 | nM | 7562947 |
NPT859 | Cell Line | HFF | Homo sapiens | IC50 | = | 30 | nM | 7562947 |
NPT91 | Cell Line | KB | Homo sapiens | IC50 | = | 30 | nM | 7562947 |
NPT137 | Cell Line | L1210 | Mus musculus | IC50 | = | 4 | nM | 7562947 |
NPT1750 | Organism | Human herpesvirus 5 | Human herpesvirus 5 | IC50 | = | 1700 | nM | 7562947 |
NPT190 | Organism | Human herpesvirus 1 | Human herpesvirus 1 | IC50 | = | 29000 | nM | 7562947 |
NPT859 | Cell Line | HFF | Homo sapiens | IC50 | = | 8000 | nM | 7562947 |
NPT91 | Cell Line | KB | Homo sapiens | IC50 | = | 17000 | nM | 7562947 |
NPT1750 | Organism | Human herpesvirus 5 | Human herpesvirus 5 | IC90 | = | 14000 | nM | 7562947 |
NPT1750 | Organism | Human herpesvirus 5 | Human herpesvirus 5 | IC50 | = | 300 | nM | 7562947 |
NPT190 | Organism | Human herpesvirus 1 | Human herpesvirus 1 | IC50 | = | 400 | nM | 7562947 |
NPT859 | Cell Line | HFF | Homo sapiens | IC50 | = | 300 | nM | 7562947 |
NPT91 | Cell Line | KB | Homo sapiens | IC50 | = | 100 | nM | 7562947 |
NPT137 | Cell Line | L1210 | Mus musculus | IC50 | = | 100 | nM | 7562947 |
NPT1750 | Organism | Human herpesvirus 5 | Human herpesvirus 5 | IC90 | = | 300 | nM | 7562947 |
NPT2603 | Individual Protein | Adenosine kinase | Homo sapiens | IC50 | = | 310 | nM | 10956196 |
NPT168 | Cell Line | P388 | Mus musculus | Activity | = | 0.0023 | ug/ml | 18327911 |
NPT2 | Others | Unspecified | IC50 | = | 3.3 | ug/ml | 1666120 | |
NPT20 | Organism | Candida albicans | Candida albicans | IZ | = | 13 | mm | 2693614 |
NPT137 | Cell Line | L1210 | Mus musculus | IC50 | = | 0.0026 | ug/ml | 2693614 |
NPT1047 | Organism | Simplexvirus | Simplexvirus | IC50 | = | 38000 | nM | 19112024 |
NPT2604 | Individual Protein | Heat shock cognate 71 kDa protein | Homo sapiens | Kd | = | 91201.08 | nM | 27119979 |
NPT2604 | Individual Protein | Heat shock cognate 71 kDa protein | Homo sapiens | Kd | = | 90000 | nM | 27119979 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC33382 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9177 | High Similarity | NPC222174 |
0.9172 | High Similarity | NPC125659 |
0.9172 | High Similarity | NPC168702 |
0.7516 | Intermediate Similarity | NPC21448 |
0.7516 | Intermediate Similarity | NPC156461 |
0.7516 | Intermediate Similarity | NPC107374 |
0.7515 | Intermediate Similarity | NPC207633 |
0.7469 | Intermediate Similarity | NPC189068 |
0.7469 | Intermediate Similarity | NPC164665 |
0.744 | Intermediate Similarity | NPC239737 |
0.7423 | Intermediate Similarity | NPC269827 |
0.7423 | Intermediate Similarity | NPC219313 |
0.7423 | Intermediate Similarity | NPC309832 |
0.7412 | Intermediate Similarity | NPC321393 |
0.7391 | Intermediate Similarity | NPC229974 |
0.7267 | Intermediate Similarity | NPC161659 |
0.7267 | Intermediate Similarity | NPC209525 |
0.7246 | Intermediate Similarity | NPC185991 |
0.7246 | Intermediate Similarity | NPC85689 |
0.7246 | Intermediate Similarity | NPC211025 |
0.7202 | Intermediate Similarity | NPC472816 |
0.7202 | Intermediate Similarity | NPC321814 |
0.7186 | Intermediate Similarity | NPC150853 |
0.7178 | Intermediate Similarity | NPC314152 |
0.716 | Intermediate Similarity | NPC317821 |
0.716 | Intermediate Similarity | NPC164952 |
0.716 | Intermediate Similarity | NPC130586 |
0.716 | Intermediate Similarity | NPC212551 |
0.716 | Intermediate Similarity | NPC302778 |
0.7118 | Intermediate Similarity | NPC174802 |
0.7099 | Intermediate Similarity | NPC129756 |
0.7076 | Intermediate Similarity | NPC224076 |
0.7066 | Intermediate Similarity | NPC121222 |
0.7035 | Intermediate Similarity | NPC226245 |
0.7035 | Intermediate Similarity | NPC316618 |
0.6941 | Remote Similarity | NPC161224 |
0.6875 | Remote Similarity | NPC107160 |
0.6839 | Remote Similarity | NPC313754 |
0.6839 | Remote Similarity | NPC311197 |
0.6839 | Remote Similarity | NPC54320 |
0.6836 | Remote Similarity | NPC323091 |
0.6829 | Remote Similarity | NPC33996 |
0.6824 | Remote Similarity | NPC136349 |
0.681 | Remote Similarity | NPC320818 |
0.6782 | Remote Similarity | NPC52238 |
0.6705 | Remote Similarity | NPC328479 |
0.6685 | Remote Similarity | NPC189261 |
0.6648 | Remote Similarity | NPC93365 |
0.6618 | Remote Similarity | NPC250178 |
0.6575 | Remote Similarity | NPC261595 |
0.6545 | Remote Similarity | NPC327941 |
0.6541 | Remote Similarity | NPC326529 |
0.6538 | Remote Similarity | NPC324033 |
0.6538 | Remote Similarity | NPC321458 |
0.6517 | Remote Similarity | NPC195140 |
0.6505 | Remote Similarity | NPC324198 |
0.6505 | Remote Similarity | NPC319100 |
0.648 | Remote Similarity | NPC138018 |
0.6471 | Remote Similarity | NPC315642 |
0.6471 | Remote Similarity | NPC74306 |
0.6467 | Remote Similarity | NPC314646 |
0.6452 | Remote Similarity | NPC158055 |
0.6429 | Remote Similarity | NPC324484 |
0.6429 | Remote Similarity | NPC62151 |
0.6413 | Remote Similarity | NPC290959 |
0.6413 | Remote Similarity | NPC326082 |
0.6407 | Remote Similarity | NPC61198 |
0.6393 | Remote Similarity | NPC325906 |
0.6364 | Remote Similarity | NPC313897 |
0.6347 | Remote Similarity | NPC262926 |
0.6328 | Remote Similarity | NPC321052 |
0.63 | Remote Similarity | NPC474767 |
0.6289 | Remote Similarity | NPC313514 |
0.6239 | Remote Similarity | NPC160666 |
0.6239 | Remote Similarity | NPC21461 |
0.6237 | Remote Similarity | NPC319456 |
0.6235 | Remote Similarity | NPC30326 |
0.6207 | Remote Similarity | NPC89147 |
0.6207 | Remote Similarity | NPC274384 |
0.619 | Remote Similarity | NPC319221 |
0.6149 | Remote Similarity | NPC211820 |
0.6149 | Remote Similarity | NPC251233 |
0.6131 | Remote Similarity | NPC324009 |
0.6127 | Remote Similarity | NPC186619 |
0.6114 | Remote Similarity | NPC177169 |
0.6098 | Remote Similarity | NPC103388 |
0.608 | Remote Similarity | NPC64705 |
0.608 | Remote Similarity | NPC232408 |
0.6057 | Remote Similarity | NPC318590 |
0.6051 | Remote Similarity | NPC24589 |
0.6041 | Remote Similarity | NPC282458 |
0.6041 | Remote Similarity | NPC78941 |
0.6034 | Remote Similarity | NPC326694 |
0.6023 | Remote Similarity | NPC317746 |
0.6 | Remote Similarity | NPC276373 |
0.599 | Remote Similarity | NPC292361 |
0.5971 | Remote Similarity | NPC5802 |
0.5942 | Remote Similarity | NPC157821 |
0.5859 | Remote Similarity | NPC62510 |
0.5851 | Remote Similarity | NPC71079 |
0.5833 | Remote Similarity | NPC89562 |
0.582 | Remote Similarity | NPC474217 |
0.5798 | Remote Similarity | NPC14590 |
0.5789 | Remote Similarity | NPC85918 |
0.5773 | Remote Similarity | NPC317054 |
0.5771 | Remote Similarity | NPC75544 |
0.5771 | Remote Similarity | NPC472289 |
0.5759 | Remote Similarity | NPC127730 |
0.5759 | Remote Similarity | NPC278366 |
0.5736 | Remote Similarity | NPC317010 |
0.5707 | Remote Similarity | NPC41333 |
0.5676 | Remote Similarity | NPC130570 |
0.5657 | Remote Similarity | NPC314491 |
0.5635 | Remote Similarity | NPC197068 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC33382 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8841 | High Similarity | NPD1046 | Clinical (unspecified phase) |
0.8529 | High Similarity | NPD1063 | Phase 2 |
0.8395 | Intermediate Similarity | NPD527 | Clinical (unspecified phase) |
0.7516 | Intermediate Similarity | NPD250 | Approved |
0.7516 | Intermediate Similarity | NPD249 | Approved |
0.7423 | Intermediate Similarity | NPD186 | Discovery |
0.7423 | Intermediate Similarity | NPD195 | Approved |
0.7407 | Intermediate Similarity | NPD5486 | Discontinued |
0.7292 | Intermediate Similarity | NPD5458 | Discontinued |
0.7246 | Intermediate Similarity | NPD283 | Approved |
0.7178 | Intermediate Similarity | NPD185 | Approved |
0.716 | Intermediate Similarity | NPD1369 | Phase 2 |
0.716 | Intermediate Similarity | NPD242 | Approved |
0.716 | Intermediate Similarity | NPD3107 | Discontinued |
0.716 | Intermediate Similarity | NPD1750 | Clinical (unspecified phase) |
0.716 | Intermediate Similarity | NPD338 | Approved |
0.715 | Intermediate Similarity | NPD2965 | Clinical (unspecified phase) |
0.7118 | Intermediate Similarity | NPD339 | Approved |
0.7091 | Intermediate Similarity | NPD166 | Approved |
0.7076 | Intermediate Similarity | NPD169 | Phase 2 |
0.7055 | Intermediate Similarity | NPD193 | Suspended |
0.7035 | Intermediate Similarity | NPD2646 | Discontinued |
0.7035 | Intermediate Similarity | NPD2624 | Phase 2 |
0.7035 | Intermediate Similarity | NPD1732 | Phase 3 |
0.7026 | Intermediate Similarity | NPD2876 | Phase 3 |
0.7026 | Intermediate Similarity | NPD2877 | Clinical (unspecified phase) |
0.7011 | Intermediate Similarity | NPD1692 | Approved |
0.7006 | Intermediate Similarity | NPD2647 | Phase 3 |
0.7 | Intermediate Similarity | NPD231 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD536 | Clinical (unspecified phase) |
0.6954 | Remote Similarity | NPD2824 | Phase 2 |
0.694 | Remote Similarity | NPD4716 | Approved |
0.6902 | Remote Similarity | NPD4744 | Clinical (unspecified phase) |
0.6839 | Remote Similarity | NPD219 | Phase 3 |
0.6839 | Remote Similarity | NPD220 | Clinical (unspecified phase) |
0.6839 | Remote Similarity | NPD217 | Approved |
0.6839 | Remote Similarity | NPD216 | Approved |
0.6839 | Remote Similarity | NPD218 | Approved |
0.6824 | Remote Similarity | NPD548 | Clinical (unspecified phase) |
0.6723 | Remote Similarity | NPD516 | Clinical (unspecified phase) |
0.6721 | Remote Similarity | NPD5666 | Phase 2 |
0.6667 | Remote Similarity | NPD214 | Approved |
0.6667 | Remote Similarity | NPD213 | Clinical (unspecified phase) |
0.665 | Remote Similarity | NPD2903 | Clinical (unspecified phase) |
0.665 | Remote Similarity | NPD2902 | Phase 2 |
0.6648 | Remote Similarity | NPD546 | Clinical (unspecified phase) |
0.6601 | Remote Similarity | NPD4563 | Phase 2 |
0.6597 | Remote Similarity | NPD2152 | Clinical (unspecified phase) |
0.6575 | Remote Similarity | NPD247 | Clinical (unspecified phase) |
0.651 | Remote Similarity | NPD207 | Discontinued |
0.6505 | Remote Similarity | NPD4171 | Clinical (unspecified phase) |
0.6503 | Remote Similarity | NPD9632 | Phase 3 |
0.6502 | Remote Similarity | NPD6351 | Discovery |
0.6484 | Remote Similarity | NPD7988 | Suspended |
0.6471 | Remote Similarity | NPD1412 | Clinical (unspecified phase) |
0.6471 | Remote Similarity | NPD582 | Approved |
0.6457 | Remote Similarity | NPD8250 | Phase 2 |
0.6452 | Remote Similarity | NPD6840 | Approved |
0.6407 | Remote Similarity | NPD252 | Clinical (unspecified phase) |
0.6406 | Remote Similarity | NPD5683 | Clinical (unspecified phase) |
0.6406 | Remote Similarity | NPD6417 | Clinical (unspecified phase) |
0.6406 | Remote Similarity | NPD5684 | Clinical (unspecified phase) |
0.6406 | Remote Similarity | NPD5682 | Phase 3 |
0.6402 | Remote Similarity | NPD248 | Discontinued |
0.64 | Remote Similarity | NPD4459 | Clinical (unspecified phase) |
0.64 | Remote Similarity | NPD4458 | Phase 2 |
0.6393 | Remote Similarity | NPD1777 | Approved |
0.6393 | Remote Similarity | NPD1776 | Approved |
0.6393 | Remote Similarity | NPD2134 | Approved |
0.6393 | Remote Similarity | NPD2136 | Approved |
0.6393 | Remote Similarity | NPD2135 | Approved |
0.6324 | Remote Similarity | NPD796 | Phase 2 |
0.6319 | Remote Similarity | NPD3083 | Approved |
0.629 | Remote Similarity | NPD5172 | Phase 2 |
0.6289 | Remote Similarity | NPD7138 | Phase 2 |
0.6286 | Remote Similarity | NPD5080 | Phase 2 |
0.6257 | Remote Similarity | NPD549 | Approved |
0.6244 | Remote Similarity | NPD1234 | Discontinued |
0.6238 | Remote Similarity | NPD5079 | Phase 2 |
0.6232 | Remote Similarity | NPD4495 | Phase 1 |
0.6227 | Remote Similarity | NPD7502 | Clinical (unspecified phase) |
0.6226 | Remote Similarity | NPD534 | Phase 2 |
0.6226 | Remote Similarity | NPD4555 | Clinical (unspecified phase) |
0.6226 | Remote Similarity | NPD537 | Phase 2 |
0.6224 | Remote Similarity | NPD2544 | Clinical (unspecified phase) |
0.6182 | Remote Similarity | NPD870 | Clinical (unspecified phase) |
0.6173 | Remote Similarity | NPD2630 | Approved |
0.6173 | Remote Similarity | NPD2632 | Approved |
0.6173 | Remote Similarity | NPD2631 | Clinical (unspecified phase) |
0.6162 | Remote Similarity | NPD2127 | Suspended |
0.6154 | Remote Similarity | NPD2872 | Phase 2 |
0.6154 | Remote Similarity | NPD194 | Clinical (unspecified phase) |
0.6114 | Remote Similarity | NPD3593 | Approved |
0.6087 | Remote Similarity | NPD4533 | Clinical (unspecified phase) |
0.6058 | Remote Similarity | NPD4612 | Discontinued |
0.598 | Remote Similarity | NPD4054 | Clinical (unspecified phase) |
0.5968 | Remote Similarity | NPD2593 | Clinical (unspecified phase) |
0.5913 | Remote Similarity | NPD1915 | Phase 1 |
0.5913 | Remote Similarity | NPD4683 | Phase 3 |
0.5909 | Remote Similarity | NPD3913 | Clinical (unspecified phase) |
0.5902 | Remote Similarity | NPD5665 | Clinical (unspecified phase) |
0.5895 | Remote Similarity | NPD9582 | Phase 3 |
0.5892 | Remote Similarity | NPD1709 | Phase 1 |
0.5892 | Remote Similarity | NPD4074 | Clinical (unspecified phase) |
0.5888 | Remote Similarity | NPD2457 | Phase 2 |
0.5888 | Remote Similarity | NPD2456 | Phase 2 |
0.5872 | Remote Similarity | NPD4187 | Clinical (unspecified phase) |
0.5862 | Remote Similarity | NPD5171 | Clinical (unspecified phase) |
0.5858 | Remote Similarity | NPD9633 | Phase 3 |
0.5857 | Remote Similarity | NPD8410 | Clinical (unspecified phase) |
0.5856 | Remote Similarity | NPD3085 | Phase 1 |
0.5851 | Remote Similarity | NPD4239 | Clinical (unspecified phase) |
0.5849 | Remote Similarity | NPD3013 | Phase 3 |
0.5849 | Remote Similarity | NPD3014 | Clinical (unspecified phase) |
0.5843 | Remote Similarity | NPD7158 | Phase 1 |
0.5829 | Remote Similarity | NPD1367 | Phase 2 |
0.5824 | Remote Similarity | NPD3086 | Phase 3 |
0.5814 | Remote Similarity | NPD6528 | Phase 1 |
0.5805 | Remote Similarity | NPD6112 | Approved |
0.5805 | Remote Similarity | NPD691 | Discontinued |
0.5803 | Remote Similarity | NPD4089 | Clinical (unspecified phase) |
0.5799 | Remote Similarity | NPD6381 | Phase 2 |
0.5797 | Remote Similarity | NPD4599 | Clinical (unspecified phase) |
0.5789 | Remote Similarity | NPD5269 | Clinical (unspecified phase) |
0.5789 | Remote Similarity | NPD3849 | Clinical (unspecified phase) |
0.5787 | Remote Similarity | NPD6772 | Clinical (unspecified phase) |
0.5782 | Remote Similarity | NPD1197 | Approved |
0.5778 | Remote Similarity | NPD1427 | Clinical (unspecified phase) |
0.5778 | Remote Similarity | NPD5627 | Approved |
0.5776 | Remote Similarity | NPD8375 | Approved |
0.5774 | Remote Similarity | NPD9408 | Phase 3 |
0.5773 | Remote Similarity | NPD2928 | Phase 2 |
0.5769 | Remote Similarity | NPD3708 | Phase 2 |
0.5764 | Remote Similarity | NPD4615 | Phase 2 |
0.575 | Remote Similarity | NPD2591 | Phase 2 |
0.5746 | Remote Similarity | NPD775 | Approved |
0.5746 | Remote Similarity | NPD8409 | Suspended |
0.5737 | Remote Similarity | NPD5925 | Phase 1 |
0.5735 | Remote Similarity | NPD3485 | Clinical (unspecified phase) |
0.5726 | Remote Similarity | NPD8371 | Clinical (unspecified phase) |
0.5721 | Remote Similarity | NPD5584 | Clinical (unspecified phase) |
0.5721 | Remote Similarity | NPD3002 | Clinical (unspecified phase) |
0.5714 | Remote Similarity | NPD8373 | Clinical (unspecified phase) |
0.5707 | Remote Similarity | NPD1675 | Phase 1 |
0.5707 | Remote Similarity | NPD9605 | Phase 3 |
0.5707 | Remote Similarity | NPD1674 | Clinical (unspecified phase) |
0.5702 | Remote Similarity | NPD4654 | Phase 1 |
0.5693 | Remote Similarity | NPD7504 | Discontinued |
0.5682 | Remote Similarity | NPD245 | Suspended |
0.5665 | Remote Similarity | NPD545 | Clinical (unspecified phase) |
0.5659 | Remote Similarity | NPD2446 | Approved |
0.5659 | Remote Similarity | NPD2362 | Approved |
0.5659 | Remote Similarity | NPD2445 | Approved |
0.5657 | Remote Similarity | NPD5508 | Phase 1 |
0.5646 | Remote Similarity | NPD2536 | Discontinued |
0.5641 | Remote Similarity | NPD5324 | Clinical (unspecified phase) |
0.5641 | Remote Similarity | NPD8291 | Clinical (unspecified phase) |
0.5637 | Remote Similarity | NPD1286 | Suspended |
0.5631 | Remote Similarity | NPD1912 | Approved |
0.5628 | Remote Similarity | NPD8321 | Discontinued |
0.5625 | Remote Similarity | NPD3287 | Clinical (unspecified phase) |
0.5616 | Remote Similarity | NPD7183 | Phase 2 |
0.5608 | Remote Similarity | NPD1335 | Approved |
0.5606 | Remote Similarity | NPD2930 | Clinical (unspecified phase) |
0.5606 | Remote Similarity | NPD1167 | Phase 3 |
PubChem CID   | 11824 |
ChEMBL   | CHEMBL99668 |
ZINC   |
Molecular Weight:   | 291.10 |
ALogP:   | -2.2444 |
MLogP:   | 1.79 |
XLogP:   | -1.915 |
# Rotatable Bonds:   | 6 |
Polar Surface Area:   | 150.44 |
# H-Bond Aceptor:   | 9 |
# H-Bond Donor:   | 4 |
# Rings:   | 3 |
# Heavy Atoms:   | 21 |